Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit

Status
Not open for further replies.

Peptidesearch

GLP-1 Enthusiast
Member Since
Jan 4, 2026
Posts
155
Likes Received
441
Location
USA
COPENHAGEN, March 9 (Reuters) - Novo Nordisk has agreed to sell its blockbuster Wegovy and Ozempic drugs through U.S. telehealth company Hims & Hers' (HIMS.N), opens new tab platform, the Danish drugmaker said on Monday, ending a legal dispute that erupted last month.

The deal marks ‌a turnaround from February, when Novo sued Hims over a $49 compounded alternative to its Wegovy weight-loss pill.

Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit

Novo Nordisk said on Monday it will sell its blockbuster Wegovy and Ozempic drugs through the U.S. telehealth company Hims & Hers Health platform, ‌ending a legal dispute that erupted last month.

www.reuters.com
 
Chili777 said:
They had an oral version for $49, got sued, signed an agreement, and now they're back up to retail prices. Everyone makes out except the consumer who is screwed once again. Unless you bought the stock at the bottom.
Big pharma strikes again 🙄 at this point when Semaglutide is allowed to be generic it will probably be sub $100 for one month
 
nitrohyper said:
Big pharma strikes again 🙄 at this point when Semaglutide is allowed to be generic it will probably be sub $100 for one month
I see telehealth and businesses based on the H&H model filling the gap. Fill out a form, or answer some questions, an MD goes over it and you get your peptides. Or at least one of the ones that they recategorize. The rest of grey is still a free-for-all.
 
Peptidesearch said:
COPENHAGEN, March 9 (Reuters) - Novo Nordisk has agreed to sell its blockbuster Wegovy and Ozempic drugs through U.S. telehealth company Hims & Hers' (HIMS.N), opens new tab platform, the Danish drugmaker said on Monday, ending a legal dispute that erupted last month .

The deal marks ‌a turnaround from February, when Novo sued Hims over a $49 compounded alternative to its Wegovy weight-loss pill.

Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit

Novo Nordisk said on Monday it will sell its blockbuster Wegovy and Ozempic drugs through the U.S. telehealth company Hims & Hers Health platform, ‌ending a legal dispute that erupted last month.

www.reuters.com

200-99c7e3763da1.gif
 

Attachments

  • 200-99c7e3763da1.gif
    200-99c7e3763da1.gif
    56.9 KB · Views: 0
Peptidesearch said:
COPENHAGEN, March 9 (Reuters) - Novo Nordisk has agreed to sell its blockbuster Wegovy and Ozempic drugs through U.S. telehealth company Hims & Hers' (HIMS.N), opens new tab platform, the Danish drugmaker said on Monday, ending a legal dispute that erupted last month .

The deal marks ‌a turnaround from February, when Novo sued Hims over a $49 compounded alternative to its Wegovy weight-loss pill.

Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit

Novo Nordisk said on Monday it will sell its blockbuster Wegovy and Ozempic drugs through the U.S. telehealth company Hims & Hers Health platform, ‌ending a legal dispute that erupted last month.

www.reuters.com
Who "saw this coming for $500 please Alex....."? Sue them to stop the undercut then acknowledge they far outperformed your marketing efforts and partner with them so both sides can rape and pillage over the population.
 
Status
Not open for further replies.

Trending content

Members online

No members online now.

Forum statistics

Threads
2,419
Messages
51,228
Members
1
Latest member
Admin
Back
Top